EUVIMEDEUVIMED entdecken
Crossref

Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS/PMOS)

Snigdha Alur-Gupta iD, Julia D DiTosto, Kyle R Busse, Jennifer Lewey iD, Daniel E Soffer, Qing Liu, Colleen Brensinger, Sunni L Mumford, Anuja Dokras

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Snigdha Alur-Gupta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of OBGYN, University of Rochester, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Metabolic Syndrome, Polycystic Ovary Syndrome, Social Determinants of Health. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute (PCORI), Board of Governors or Methodology Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

No studies have explored racial differences in atherosclerotic cardiovascular disease (ASCVD) in women with polycystic ovary syndrome (PCOS), which is now known as polyendocrine metabolic ovarian syndrome (PMOS).

Objective

Compare ASCVD risk by race/ethnicity among women with PMOS and determine whether social determinants of health (SDoH) drive associations.

Design

Cohort study.

Setting

Optum's de-identified Clinformatics® Data Mart Database (2000-2022).

Participants

Women aged 18 to 50 with PMOS using PCOS International Classification of Diseases 9/10 codes. Race/ethnicity was categorized as White, Black, Asian, or Hispanic.

Interventions

None. Main Outcome Measures Primary outcome was risk of composite ASCVD (coronary artery disease, cerebrovascular disease, peripheral artery disease). Secondary outcomes included each component. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models that were unadjusted (Model 1), adjusted for medical comorbidities (Model 2), and adjusted for comorbidities plus SDoH: homeownership, net worth, and education (Model 3).

Results

The sample included 413 450 women with PMOS. Accounting for medical comorbidities (Model 2), Asian women with PMOS were at a lower risk for ASCVD compared with White women (aHR, .65; 95% CI, .56-.74), and Black (aHR, 1.10; 95% CI, 1.02-1.19) and Hispanic women (aHR, 1.21; 95% CI, 1.12-1.29) were at a higher risk. After adjusting for SDoH (Model 3), the findings for Asian and Hispanic women remained significant, whereas those for Black women did not. When looking at individual components of ASCVD, the higher risk for multiple components among Black women was no longer significant after controlling for SDoH.

Conclusion

Racial differences exist in risk of ASCVD among women with PMOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMetabolic SyndromePolycystic Ovary SyndromeSocial Determinants of HealthAdolescentAdultFemaleHumansMiddle AgedYoung AdultCohort StudiesComorbidityEthnicityRisk FactorsSocioeconomic Disparities in HealthWhiteAsianBlack or African AmericanHispanic or LatinoRacial Groups

Stichwörter der Autor:innen

ASCVDPMOSethnicityracesocial determinants of health

Autor:innen und Institutionen

  • Department of OBGYN, University of Rochester, Rochester, NY 14642, USA.
  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Department of OBGYN, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Snigdha Alur-Gupta, Jennifer Lewey

Förderung

  • Patient-Centered Outcomes Research Institute (PCORI)
  • Board of Governors or Methodology Committee

Zitieren

APA

Alur-Gupta, S., DiTosto, J. D., Busse, K. R., Lewey, J., Soffer, D. E., Liu, Q., Brensinger, C., Mumford, S. L., & Dokras, A. (2026). Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS/PMOS). The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag308

Vancouver

Alur-Gupta S, DiTosto JD, Busse KR, Lewey J, Soffer DE, Liu Q, et al. Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS/PMOS). The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag308

BibTeX
@article{AlurGupta2026,
  author = {Alur-Gupta, Snigdha and DiTosto, Julia D and Busse, Kyle R and Lewey, Jennifer and Soffer, Daniel E and Liu, Qing and Brensinger, Colleen and Mumford, Sunni L and Dokras, Anuja},
  title = {Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS/PMOS)},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag308}
}
Kostenlos starten →